"Market research of 51 oncologists in October 2017, shows that 61% invested in technology and staffing to prepare for MACRA, significantly higher than 29% noted in February 2017. Despite this investment, oncologists have remained skeptical on MACRA’s ability to improve patient outcomes (72%) and reduce total cost of care (51%), while assuring practices’ financial viability (45%)."

Excerpted from: Accountable Care News, Volume 8 Number 12, November 2017, "The Oncology Care Model at Two Years: What We Know and Don't Know ," by Bruce Feinberg, D.O., Chadi Nabhan, M.D., Robin Frink, Ph.D., and Martie Ross